+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lung cancer treated surgically in patients <50 years of age

Lung cancer treated surgically in patients <50 years of age

Chest 120(1): 32-36

Study objectives: Some investigators have suggested that lung cancer in young patients has a more aggressive course and a poorer prognosis than lung cancer in older patients. The aim of this study was to determine if the basal characteristics and survival in younger patients with lung cancer undergoing surgical resection differ from those of older patients. Design: Retrospective clinical study. Patients: Of 1,208 consecutive patients who underwent surgery for primary lung cancer between June 1984 and March 2000, we reviewed the medical records of 110 younger patients who were <50 years of age at the time of surgery and compared them with 1,098 older patients (gtoreq50 years of age). All deaths were included. Results: In the younger patient group, asymptomatic disease and adenocarcinoma was significantly more frequent, the rate of smoking was significantly higher, and the amount of smoking (Brinkman index) was significantly larger. For the 94 younger patients with complete resection, the 5-year survival rate was 61.0%, which was not significantly higher than that for the 923 older patients (57.7%). However, the 53 younger patients with stage I disease (5-year survival of 84.3%) had significantly better survival than older patients with the same condition (71.6%). Survival of patients in stage II or stage III disease was not significantly different. Conclusion: The younger patients had significantly better prognoses, and a statistical difference was shown especially in the early stage, while in the advanced stage the malignancy of the lung cancer itself surpassed the difference in survival.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 010943318

Download citation: RISBibTeXText

PMID: 11451812

DOI: 10.1378/chest.120.1.32

Related references

Metachronous second primary lung cancer surgically treated five years or more after the initial surgery. Molecular and Clinical Oncology 3(5): 1025-1028, 2015

Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer. Clinical Lung Cancer 18(6): E457-E466, 2017

Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening?. Erj Open Research 4(3):, 2018

Clinical properties of CYFRA 21-I tumour marker in surgically treated lung cancer marker in surgically treated lung cancer. European Respiratory Journal 7(Suppl. 18): 267S, 1994

Survival of patients surgically treated for lung cancer. Medical Journal of Malaysia 58(4): 490-498, 2003

On undiagnosed metastases in patients surgically treated for cancer of the lung. Grudnaia Khirurgiia 4: 26-30, 1962

Survival of patients surgically treated for stage I lung cancer. Journal of Thoracic and Cardiovascular Surgery 82(1): 70-76, 1981

Primary lung cancer in young patients a study of 82 surgically treated patients. Annals of Thoracic Surgery 54(1): 99-103, 1992

Changes in gas exchange and tissue circulation in patients with surgically treated lung cancer. Grudnaia Khirurgiia .(5): 34-36, 1983

Survival of surgically treated lung cancer patients according to P53 status of the tumor. European Respiratory Journal Suppl. 9(23): 11S, 1996

Reversal of digital clubbing in surgically treated lung cancer patients. Jornal Brasileiro de Pneumologia 34(7): 481-489, 2008

Urban vs. rural patients. Differences in stage and overall survival among patients treated surgically for lung cancer. Annals of Agricultural and Environmental Medicine 20(1): 101-105, 2013

Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan. Lung Cancer 36(1): 65-69, 2002

Preoperative thrombocytosis in surgically treated patients with non-small cell lung cancer. Polish Archives of Internal Medicine 128(9): 512-517, 2018

Nucleolar organizer regions as a prognostic factor in surgically treated lung cancer patients. Thoracic and Cardiovascular Surgeon 44(4): 204-207, 1996